APA
Atalar E., Ozturk E., Ozer N., Haznedaroglu I. C., Kepez A., Coskun S., Aksoyek S., Ovunc K., Kes S., Kirazli S. & Ozmen F. (20061025). Plasma soluble osteopontin concentrations are increased in patients with rheumatic mitral stenosis and associated with the severity of mitral valve calcium. : The American journal of cardiology.
Chicago
Atalar Enver, Ozturk Ercan, Ozer Necla, Haznedaroglu Ibrahim C, Kepez Alper, Coskun Selcuk, Aksoyek Serdar, Ovunc Kenan, Kes Sirri, Kirazli Serafettin and Ozmen Ferhan. 20061025. Plasma soluble osteopontin concentrations are increased in patients with rheumatic mitral stenosis and associated with the severity of mitral valve calcium. : The American journal of cardiology.
Harvard
Atalar E., Ozturk E., Ozer N., Haznedaroglu I. C., Kepez A., Coskun S., Aksoyek S., Ovunc K., Kes S., Kirazli S. and Ozmen F. (20061025). Plasma soluble osteopontin concentrations are increased in patients with rheumatic mitral stenosis and associated with the severity of mitral valve calcium. : The American journal of cardiology.
MLA
Atalar Enver, Ozturk Ercan, Ozer Necla, Haznedaroglu Ibrahim C, Kepez Alper, Coskun Selcuk, Aksoyek Serdar, Ovunc Kenan, Kes Sirri, Kirazli Serafettin and Ozmen Ferhan. Plasma soluble osteopontin concentrations are increased in patients with rheumatic mitral stenosis and associated with the severity of mitral valve calcium. : The American journal of cardiology. 20061025.